Skip to main content
    N

    Neuraxis, Inc. (NRXS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $4.83
    -0.59 (-10.89%)

    Market Cap: $76.93M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Neuraxis, Inc. (NRXS) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Neuraxis are Neumora Therapeutics (NMRA), Minerva Neurosciences (NERV) and NRX Pharmaceuticals (NRXP). By market cap, Neuraxis ranks 8th of the 13 companies on this page; Minerva Neurosciences (NERV) is the largest at $114.62M.

    Peer Comparison

    NRXS's revenue growth of 115.7% is above the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Neuraxis (NRXS)$76.93MN/A9.6x-144.4%-247.7%115.7%0.00%
    Neumora Therapeutics, Inc. (NMRA)$80.59MN/AN/A0.0%-260.5%0.0%0.00%
    Minerva Neurosciences Inc (NERV)$114.62MN/AN/A0.0%N/A0.0%0.00%
    NRX Pharmaceuticals Inc (NRXP)$95.58MN/A23.8x0.0%N/A0.0%0.00%
    Tenax Therapeutics Inc (TENX)$73.77MN/AN/A0.0%N/A0.0%0.00%
    Nkarta Inc (NKTX)$85.23MN/AN/A0.0%N/A0.0%0.00%
    Tonix Pharmaceuticals Holding Corp (TNXP)$58.49MN/A1.2x0.0%N/A423.8%0.00%
    Mink Therapeutics Inc (INKT)$47.95MN/A236.3x0.0%N/A0.0%0.00%
    Cingulate Inc (CING)$62.53MN/AN/A0.0%N/A0.0%0.00%
    Immunic Inc (IMUX)$102.61MN/AN/A0.0%N/A0.0%0.00%
    Anixa Biosciences Inc (ANIX)$91.08MN/AN/A0.0%N/A0.0%0.00%
    Verrica Pharmaceuticals Inc (VRCA)$61.16MN/A3.0x-189.2%-496.2%-51.8%0.00%
    Voyager Therapeutics Inc (VYGR)$107.66MN/A4.0x0.0%N/A-70.0%0.00%
    Peer median$82.91MN/A4.0x0.0%-378.4%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Neuraxis, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Neumora Therapeutics, Inc. (NMRA)
    Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases...
    NMRA competitors
    Minerva Neurosciences Inc (NERV)
    Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of candidate products...
    NERV competitors
    NRX Pharmaceuticals Inc (NRXP)
    NRx Pharmaceuticals, Inc., a clinical-stage small molecule pharmaceutical company...
    NRXP competitors
    Tenax Therapeutics Inc (TENX)
    Tenax Therapeutics, Inc., a specialty pharmaceutical company, is dedicated to identifying, developing...
    TENX competitors
    Nkarta Inc (NKTX)
    Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and markets cell therapies for the treatment of cancer.
    NKTX competitors
    Tonix Pharmaceuticals Holding Corp (TNXP)
    Tonix Pharmaceuticals Holding Corp. The company is headquartered in Chatham, New Jersey.
    TNXP competitors
    Mink Therapeutics Inc (INKT)
    MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of allogeneic...
    INKT competitors
    Cingulate Inc (CING)
    Cingulate Inc., a clinical-stage biopharmaceutical company, is focused on developing candidate products for the treatment of neurobiological and central nervous...
    CING competitors
    Immunic Inc (IMUX)
    Immunic, Inc., a clinical-stage biopharmaceutical company, develops a line of selective oral immunology therapies for the treatment of chronic autoimmune...
    IMUX competitors
    Anixa Biosciences Inc (ANIX)
    Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases.
    ANIX competitors
    Verrica Pharmaceuticals Inc (VRCA)
    Verrica Pharmaceuticals Inc., a dermatological therapy company, develops and markets treatments for people with skin conditions in the United States.
    VRCA competitors
    Voyager Therapeutics Inc (VYGR)
    Voyager Therapeutics, Inc., a clinical-stage gene therapy company, is focused on developing treatments for patients with severe neurological diseases.
    VYGR competitors

    Frequently Asked Questions About NRXS

    Who are Neuraxis' main competitors?

    The companies most similar to Neuraxis include Neumora Therapeutics (NMRA), Minerva Neurosciences (NERV), NRX Pharmaceuticals (NRXP), Tenax Therapeutics (TENX) and Nkarta (NKTX), listed from the closest match.

    Who is Neuraxis' biggest competitor?

    Minerva Neurosciences (NERV) is the largest of the similar companies at $114.62M; Neumora Therapeutics (NMRA) is the closest match by business profile, size, sector and industry.

    How does NRXS stock compare with its competitors?

    NRXS' P/S is 9.6x against a peer median of 4.0x; its net margin is -144.4% against a peer median of 0.0%.

    Which of Neuraxis' competitors pays a higher dividend?

    Neuraxis pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Neuraxis bigger than its competitors?

    No. Neuraxis is 8th by market cap among the 13 companies on this page; the largest is Minerva Neurosciences (NERV) at $114.62M.